IDEX Biometrics ASA (IDBA)
IDEX Biometrics ASA Statistics
Share Statistics
IDEX Biometrics ASA has 18.6M shares outstanding. The number of shares has increased by 0% in one year.
Shares Outstanding | 18.6M |
Shares Change (YoY) | 0% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 15.06M |
Failed to Deliver (FTD) Shares | 296 |
FTD / Avg. Volume | 20.86% |
Short Selling Information
The latest short interest is 32, so 0% of the outstanding shares have been sold short.
Short Interest | 32 |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -2.57 and the forward PE ratio is null. IDEX Biometrics ASA's PEG ratio is 0.
PE Ratio | -2.57 |
Forward PE | n/a |
PS Ratio | 16.53 |
Forward PS | null |
PB Ratio | 6.04 |
P/FCF Ratio | -2.51 |
PEG Ratio | 0 |
Enterprise Valuation
IDEX Biometrics ASA has an Enterprise Value (EV) of 64.2M.
EV / Sales | 15.46 |
EV / EBITDA | -2.48 |
EV / EBIT | -2.37 |
EV / FCF | -2.35 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.45.
Current Ratio | 1.64 |
Quick Ratio | 1.12 |
Debt / Equity | 0.45 |
Debt / EBITDA | -0.27 |
Debt / FCF | -0.25 |
Interest Coverage | -40.38 |
Financial Efficiency
Return on Equity is -234.95% and Return on Invested Capital is -163.51%.
Return on Equity | -234.95% |
Return on Assets | -106.68% |
Return on Invested Capital | -163.51% |
Revenue Per Employee | $52.56K |
Profits Per Employee | $-338.14K |
Employee Count | 79 |
Asset Turnover | 0.17 |
Inventory Turnover | 0.61 |
Taxes
Income Tax | -15.66K |
Effective Tax Rate | 0.06% |
Stock Price Statistics
The stock price has increased by 9.66% in the last 52 weeks. The beta is 1.97, so IDEX Biometrics ASA's price volatility has been higher than the market average.
Beta | 1.97 |
52-Week Price Change | 9.66% |
50-Day Moving Average | 5.01 |
200-Day Moving Average | 6.47 |
Relative Strength Index (RSI) | 30.02 |
Average Volume (20 Days) | 1.42K |
Income Statement
In the last 12 months, IDEX Biometrics ASA had revenue of 4.15M and earned -26.71M in profits. Earnings per share was -1.07.
Revenue | 4.15M |
Gross Profit | 231.73K |
Operating Income | -26.93M |
Net Income | -26.71M |
EBITDA | -25.9M |
EBIT | -274.88M |
Earnings Per Share (EPS) | -1.07 |
Balance Sheet
The company has 11.39M in cash and 6.96M in debt, giving a net cash position of 4.43M.
Cash & Cash Equivalents | 11.39M |
Total Debt | 6.96M |
Net Cash | 4.43M |
Retained Earnings | -331.07M |
Total Assets | 27.08M |
Working Capital | 15.68M |
Cash Flow
In the last 12 months, operating cash flow was -27.09M and capital expenditures -243.77K, giving a free cash flow of -27.33M.
Operating Cash Flow | -27.09M |
Capital Expenditures | -243.77K |
Free Cash Flow | -27.33M |
FCF Per Share | -0.11 |
Margins
Gross margin is 5.58%, with operating and profit margins of -648.63% and -643.37%.
Gross Margin | 5.58% |
Operating Margin | -648.63% |
Pretax Margin | -643.75% |
Profit Margin | -643.37% |
EBITDA Margin | -623.82% |
EBIT Margin | -648.63% |
FCF Margin | -658.32% |
Dividends & Yields
IDBA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -38.93% |
FCF Yield | -39.83% |
Analyst Forecast
Currently there are no analyst rating for IDBA.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -11.9 |
Piotroski F-Score | 2 |